Viking Therapeutics News and Activities

Presence

Viking Therapeutics develops medicines for metabolic and endocrine diseases. Its main products are drug candidates for obesity, fatty liver disease, and rare disorders, serving patients through healthcare providers and future pharmaceutical partners.

Viking Therapeutics products and services overview:

  • Obesity treatments
  • Liver disease therapies
  • Endocrine therapies
  • Rare disease drugs

Revenue: ~$0 million

Employees: 38

Headquarters: San Diego, United States (USA)


Viking Therapeutics is one of the...

Viking Therapeutics is a company listed under the stock ticker VKTX (US).

Executives

View the org chart displaying its 23 main executives

Most searched biographies at Viking Therapeutics
Popular executive movements at Viking Therapeutics
  • Elena Korobetskaya has joined the company as Executive Director, Analytical Development  (posted on January 7 2026).
  • Neil Aubuchon has joined the company as Chief Commercial Officer  (posted on January 7 2026).

Create your alert
to follow the executive moves at Viking Therapeutics.

News

Press releases by Viking Therapeutics
Social media about Viking Therapeutics

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.